NextCell Pharma   Report issue

For profit Phase 2
Founded: Huddinge Sweden (2014)

Organization Overview

First Clinical Trial
2017
NCT03406585
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

NextCell Pharma | NextCell Pharma Ab